LCN2 and acute lymphoblastic leukemia: Similarly, research by Latoch et al. (2020) evaluated KIM-1 and NGAL as markers of tubular injury in acute lymphoblastic leukemia survivors, demonstrating their effectiveness in detecting acute kidney injury and highlighting their potential utility in monitoring nephrotoxicity during chemotherapy [28].